Chemotherapy-induced peripheral neuropathy: prevention and treatment. - Wikidata - awgldk - TriplyDB

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

http://www.wikidata.org/entity/Q37911252

about

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline Mechanisms of acupuncture-electroacupuncture on persistent pain Neurotoxicity associated with cancer therapy Pharmacogenomics of chemotherapeutic susceptibility and toxicity Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity Coadministration of indomethacin and minocycline attenuates established paclitaxel-induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic mice The anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse model Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles induces proliferation inhibition and apoptosis in ovarian cancer cells The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity.Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine.Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer.Chemotherapy-induced polyneuropathy. Part I. Pathophysiology.Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.Sensory neuron subpopulation-specific dysregulation of intracellular calcium in a rat model of chemotherapy-induced peripheral neuropathy.New tools for the quantitative assessment of prodrug delivery and neurotoxicity.Nuclear mapping of nanodrug delivery systems in dynamic cellular environments Pharmacoethnicity in Paclitaxel-Induced Sensory Peripheral Neuropathy Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment.Effect of Vitamin E on Oxaliplatin-induced Peripheral Neuropathy Prevention: A Randomized Controlled Trial.Chemotherapy-induced peripheral neuropathy: Current status and progress.Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics follo Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy.Efficacy of contact needle therapy for chemotherapy-induced peripheral neuropathy Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.A systematic review of experimental and clinical acupuncture in chemotherapy-induced peripheral neuropathy Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study.Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture.Neurological Adverse Effects in Patients of Advanced Colorectal Carcinoma Treated with Different Schedules of FOLFOX Herbal Medicine Goshajinkigan Prevents Paclitaxel-Induced Mechanical Allodynia without Impairing Antitumor Activity of Paclitaxel.Efficacy of Japanese traditional (Kampo) medicine for treating chemotherapy-induced peripheral neuropathy: A retrospective case series study.Women Treated for Breast Cancer Experiences of Chemotherapy-Induced Pain: Memories, Any Present Pain, and Future Reflections.A prospective validation pharmacogenomic study in the adjuvant setting of colorectal cancer patients treated with the 5-fluorouracil/leucovorin/oxaliplatin (FOLFOX4) regimen.

P2860

Q26773986-C542E6E5-853F-46FF-A75C-F226F5CE5E50 Q26866252-774E7D51-26F3-413D-9630-6408F5CF7B00 Q27004714-432BE556-D31F-456C-B326-03DE6AD99B86 Q27025558-D4D10931-F47B-4544-A890-908F618A9677 Q27305830-174C523D-614F-49C8-B4C5-6E82E3819EFF Q28315016-B0CFD796-6B69-4301-BB00-E7E0DEC97C94 Q28484947-890DD7B7-1CD1-4348-A3CD-83C7C7F43FE8 Q28536340-99F292CE-68A8-4E5A-B127-6A32E5C0DEB3 Q28539926-BFC87A81-EA29-4153-874F-EC06061DA5D4 Q30421395-7C4AD5D6-34DF-4025-844B-CF8F84C7EBB1 Q33672384-E704A1F2-9990-4BA4-89F4-14A3DBAB114A Q33851503-B6CB1E44-3BB3-4820-8E0C-35E07B93BE3A Q33889319-EBA1EB26-97EB-4EA4-AF0C-CF5AA24EE87E Q34403197-C79225AE-948D-49AB-ACD9-9D00EF700FF3 Q34458581-0BD367C9-75E4-42FD-A749-6749EED2646E Q34653461-6D416B1F-0742-4DD3-89E5-C463ABAE219F Q35100937-4E7A6EEC-978E-4EA5-990B-A497FF9C78B6 Q35143365-214B1E46-A771-4629-AFC4-2F50D6B809A2 Q35438322-2867A3E2-6BBA-4376-9E77-DF050F5A75E7 Q35745959-3C4CECAE-D951-47EF-A9C7-CBB81D35488B Q35798221-11701652-470A-4460-B5D0-AD7D01294FDD Q35849165-29E9F3A1-9B4E-4F53-A389-E7137698E863 Q36060654-7C8A7FB6-7828-4800-BCE6-B648416ECC85 Q36117686-C8AD7182-0E0F-4022-B92D-356299FC41E2 Q36329774-7179140A-4559-4379-9B22-76B67055EEF7 Q36350645-5D097F04-2F00-48DE-8F47-1945E5E35909 Q36421901-4B82EC63-DDE7-4EAC-B67E-585276B154F7 Q36439933-37066B1A-4E4E-4BA2-BCAD-2ADED5BC4290 Q36476481-AB5E241F-E5F9-4C30-9C79-FCA6466B1E7D Q36545157-B3E9D2BA-557E-4043-B9AF-F635EB988CA2 Q36900091-537AE690-DA53-40C5-85B8-761F5C69349B Q37067999-7163CFAF-7919-4AE7-8E07-69582F099FAB Q37091093-F0ADA066-F4BB-4D1E-829C-CC0F33A79146 Q37143510-8BC2EC7C-76B9-4B0C-8E35-3947CF25B654 Q37166705-F46F6141-2B00-4B6C-B37D-6401D729324F Q37244795-5AC9C9FB-0158-4BB2-91F5-DF99CE47A7C1 Q37254133-BA71B1F8-DF41-4F87-9967-E0A0B3D2F268 Q37345334-240FC717-0A6D-4555-8FEA-5FFA6268364E Q37346555-64175899-7CCD-4577-A5CC-A74B324CDD72 Q37383249-DFC6D4C8-A073-4BA8-BC80-7EB00B6CE586

P2860

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

http://www.wikidata.org/entity/Q37911252

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

@en

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

@nl

type

label

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

@en

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

@nl

prefLabel

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

@en

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

@nl

P1433

Q37911252-11DA5CBB-8514-4ADF-A50A-00411BA9AAAA

P1476

Q37911252-B034DBD9-C7C7-4C39-BF51-834EAFD840E4

P2093

Q37911252-78A5EA06-C055-4B55-98DA-92EC039E573B

Q37911252-8E349A1F-101C-4FD6-935D-F137A67A94C7

Q37911252-C797BC69-C2FE-4748-8223-BD388BCC853B

Q37911252-F08F5F96-3DB1-454D-ACF8-0783E4A7D08A

P2860

Q37911252-01032377-E2EA-4262-90D7-8001E29ACDA3

Q37911252-03CC3D92-1F13-46F7-AE80-4F3036DBB82B

Q37911252-06876E1E-4771-43AB-AF7A-3A4E07697F72

Q37911252-0B41D65A-54B2-4328-9328-78F209E6026F

Q37911252-14D4BB98-5BC7-49C5-A754-CDB4C097068A

Q37911252-26DFA473-4CEB-4BF3-8DA4-830B80AC5F0E

Q37911252-2A9308A4-D8BB-487F-AF9C-2A34C3D5CA1E

Q37911252-2B8B302C-E3A2-41D8-9017-DFFD32F324DB

Q37911252-30F1710B-569C-4283-AD34-BA452A25332D

Q37911252-37977AE3-ECB6-46E4-9C36-D6DA2F49FBD4

P2888

Q37911252-92C0C6D9-7272-4C61-BE40-3FF3ECA4AE86

P304

Q37911252-DDB16B91-1032-4197-80CB-2E5A9609C195

P31

Q37911252-63A9DB23-5A5E-47F5-8E2B-7CAD93D9915C

P356

Q37911252-88C916EF-5915-46CA-8728-09A3F2FD2C3A

P407

Q37911252-899AF7A1-B761-40E8-9EB1-AB685ADF7855

P433

Q37911252-FCA86FBC-A3E6-4500-84C5-91677701DCF8

P478

Q37911252-B98172D9-54B3-4CFE-B4B1-5BDA8CF01AA4

P577

Q37911252-9256D770-7BB1-4D33-BCF9-D2C6380977E9

P5875

Q37911252-74F1E4AE-48D4-45B7-84E4-1A7AE8DAFD40

P6179

Q37911252-BC43D799-91FF-4062-8B84-13CC8A4E9910

P698

Q37911252-93427E57-DBCD-4C4B-BE4B-785A4E2BD117

P921

Q37911252-73DBBF82-3261-4934-B525-BF76431B103F

P356

P1433

Clinical Pharmacology & Therapeutics

P1476

Chemotherapy-induced peripheral neuropathy: prevention and treatment.

@en

P2093

C L Loprinzi

http://www.w3.org/2001/XMLSchema#string

D L Barton

http://www.w3.org/2001/XMLSchema#string

D R Pachman

http://www.w3.org/2001/XMLSchema#string

J C Watson

http://www.w3.org/2001/XMLSchema#string

P2860

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials

Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials

N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data.

Acetyl-L-carnitine in neuropathic pain: experimental data.

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.

Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice

EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision.

Electrotherapy for the treatment of painful diabetic peripheral neuropathy: a review.

Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.

Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study.

P2888

P304

377-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2011.115

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51545049

http://www.w3.org/2001/XMLSchema#string

P6179

1025189218

http://www.w3.org/2001/XMLSchema#string

P698

21814197

http://www.w3.org/2001/XMLSchema#string

P921